$XENE
Xenon Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
$39.80
▼-30.60%-$17.55
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateXenon Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is XENE down today? It is at $39.80 (-30.60%), and our scanner flagged it 95 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment XENE spikes, and full due diligence on XENE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $XENE 95 times in the last 30 days. Create a free account to track $XENE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on XENE from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Latest filing4Insider trade (Form 4)Sep 4, 2026 · 16 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Svoronos Dawn Director | Other | 5K | added 20% | 31K | $42K at $8.15 | Sep 1, 26 |
Kenney Christopher John Officer | Sold (automatic/other) | -7K | sold 100% | 2 | $425K at $60.17 | Aug 28, 26 |
Gannon Steven Director | Sold (automatic/other) | -10K 0.01% of company | sold 84% | 2K | $641K at $64.06 | Aug 11, 26 |
Cannon Gillian Director | Sold (automatic/other) | -1K | sold 45% | 1K | $63K at $53.14 | Jun 5, 26 |
Patou Gary Director | Sold (automatic/other) | -1K | sold 5.0% | 25K | $70K at $53.14 | Jun 5, 26 |
Svoronos Dawn Director | Sold (automatic/other) | -1K | sold 5.1% | 26K | $76K at $53.41 | Jun 1, 26 |
Svoronos Dawn Director | Other | 3K | added 11% | 28K | n/a | Jun 1, 26 |
Cannon Gillian Director | Other | 3K | n/a | 3K | n/a | Jun 1, 26 |
Gannon Steven Director | Sold (automatic/other) | -1K | sold 11% | 12K | $76K at $53.41 | Jun 1, 26 |
Gannon Steven Director | Other | 3K | added 25% | 13K | n/a | Jun 1, 26 |
Garofalo Elizabeth A. Director | Other | 3K | n/a | 3K | n/a | Jun 1, 26 |
Gover Justin D. Director | Other | 3K | n/a | 3K | n/a | Jun 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on XENE from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
XENE last traded at $39.80, down 30.60% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Xenon Pharmaceuticals Inc (XENE) is next expected to report earnings on Monday, November 2, 2026, about 43 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The XENE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged XENE 95 times in the last 30 days.
XENE (Xenon Pharmaceuticals Inc) trades on XNAS, with a market cap of about $3.85B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge XENE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$XENE discussion
Sign in to ask a question or join the discussion.